STAT

LISTEN: Using the word ‘cure,’ an FDA loophole, & making biotech history

Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its shadow in 2019? Find out in the latest episode…

Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
23andMe Laying Off 14% Of Employees Amid Slump In DNA Spit Kit Sales
In the latest sign of a slump in consumer genetic testing, 23andMe is laying off 14% of its workforce amid falling sales of its DNA spit kits.
STAT4 min readSociety
‘Traumatic As Hell’: Patients Describe What It’s Like To Be Restrained In The ER
Researchers interviewed 25 patients who’d been physically restrained in the ER about the experience and the effect it had on their mental and physical health.
STAT1 min readSociety
STAT Health Tech Summit
About Where health tech meets biotech Breakthroughs in health and medicine are not just biological — they’re technological. Join us for our next STAT Summit as we assemble top executives,…